Medical Weight Loss in Troy, MI

Some prescription medicines help you feel less hungry and full sooner. We review your health history and current medicines before deciding whether treatment is right for you.

Which FDA-approved medications might we discuss?

• Wegovy (semaglutide): a weekly injection or a daily pill.
• Wegovy HD (semaglutide): a higher-dose, 7.2 mg weekly injection for certain adults.
• Saxenda (liraglutide): a daily injection.
• Zepbound (tirzepatide): a weekly injection.
• Foundayo (orforglipron): a daily pill.

These medicines act on pathways that help regulate appetite. Wegovy, Wegovy HD, Saxenda, and Foundayo target GLP-1. Zepbound targets both GLP-1 and GIP. We will explain the options, dosing, and what to expect before you start.

How much weight could I lose?

Weight loss takes time. These are average results from selected adult studies of the injection doses shown below, alongside changes in eating and physical activity. They do not describe results with pills or Wegovy HD:

Percentages refer to starting body weight. These separate studies involved different patients and are not a direct comparison. Results vary with dose, consistency, health conditions, and lifestyle. Weight loss is often lower in people with type 2 diabetes. These figures are not a guarantee or dosing instructions.

What’s new in weight-loss treatment?

More treatment choices are becoming available. The Wegovy pill was FDA-approved in December 2025, followed by Wegovy HD in March 2026 and Foundayo in April 2026.

The two pills have different instructions. Foundayo can be taken with or without food. Take the Wegovy pill in the morning on an empty stomach with no more than 4 ounces of plain water, then wait at least 30 minutes before food, drinks, or other oral medicines.

Wegovy HD provides another injection option for certain adults who need additional weight loss. We will review whether the higher dose fits your needs and discuss side effects, including possible changes in skin sensation.

Other treatments are still being studied:

• Retatrutide targets three hormone pathways: GLP-1, GIP, and glucagon. In a late-stage trial called TRIUMPH-1, the manufacturer reported about 28% average weight loss at 80 weeks with the 12 mg dose, in adults without diabetes. Safety and effectiveness are still being studied.
• CagriSema combines semaglutide with cagrilintide, another medicine being studied to help regulate appetite. Its application is under FDA review.

Retatrutide and CagriSema are not FDA-approved and are not available as routine prescriptions. Trial results do not guarantee an individual’s outcome. We follow new research and approvals and will discuss which options may be appropriate for you as they become available.

New-treatment information checked October 9, 2026. Approval status and availability may change.

What side effects can GLP-1 medicines cause?

Nausea, vomiting, diarrhea, constipation, stomach discomfort, and heartburn can occur. Many symptoms improve with time. Starting at a low dose and increasing gradually may help. Contact us if symptoms persist, worsen, or make it hard to eat or drink.

Important FDA warning about thyroid tumors

Wegovy, Wegovy HD, Saxenda, Zepbound, and Foundayo carry a boxed warning, the FDA’s strongest warning, about thyroid C-cell tumors. The warning is based on animal findings with medicines in this group; whether the risk applies to people is not known. Tell us promptly about a neck lump, ongoing hoarseness, or trouble swallowing. Trouble breathing needs immediate attention.

Who should avoid GLP-1 or GLP-1/GIP medicines?

Do not take the medication if you have:

• A personal or family history of medullary thyroid carcinoma (MTC), a specific type of thyroid cancer.
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• A previous serious allergic reaction to that medicine or one of its ingredients.

Pregnancy: Do not use these medicines for weight loss during pregnancy. Discuss pregnancy plans before starting. Semaglutide should be stopped at least two months before a planned pregnancy.

Taking birth-control pills? Use a non-oral method or add a barrier method, such as condoms, for four weeks with Zepbound or 30 days with Foundayo after starting and after each dose increase.

Tell us about severe slow stomach emptying (gastroparesis), previous pancreatitis, kidney or liver problems, diabetic eye disease, breastfeeding, and any planned anesthesia or sedation. Insulin and certain diabetes pills can raise the risk of low blood sugar when combined with these medicines.

Other FDA-approved weight-loss medications

GLP-1 medicines are one option. Depending on your health history, other treatments may be worth discussing:

• Contrave (naltrexone/bupropion): A prescription pill that combines two medicines to help manage hunger. It is approved for long-term weight management. It is not suitable for people with uncontrolled high blood pressure, a history of seizures, or regular opioid use.
• Qsymia (phentermine/topiramate): A daily prescription pill that helps reduce appetite and is approved for long-term weight management. It can cause birth defects; people who can become pregnant need effective birth control and pregnancy testing before treatment and monthly during treatment.
• Xenical and Alli (orlistat): These reduce the amount of fat your body absorbs from food. Xenical requires a prescription; lower-dose Alli is available over the counter for adults. Oily stools and an urgent need to use the bathroom can occur.
• Adipex-P and Lomaira (phentermine): Prescription appetite suppressants approved for short-term use, usually a few weeks. They can raise blood pressure or heart rate and are not suitable for everyone.
• Other short-term appetite suppressants: These include benzphetamine (previously sold as Didrex and Regimex), diethylpropion, and phendimetrazine. These older medicines require careful medical review and monitoring. Availability varies.
• Imcivree (setmelanotide): A targeted injection for certain rare genetic forms of obesity, including Bardet-Biedl syndrome, and for acquired hypothalamic obesity—a rare condition caused by injury or dysfunction in the brain’s appetite-control center. It requires a specific diagnosis and is not a treatment for general obesity. We can discuss whether specialist evaluation is appropriate.

Each medicine has its own benefits, risks, and interactions. We will review these with you before choosing treatment. Do not combine weight-loss medicines or supplements unless your clinician recommends it.

Will I need treatment long term?

Obesity is a chronic condition. Medicines approved for long-term use may be continued if they are helping and remain safe. Short-term medicines have different treatment limits. Weight regain is common after stopping. We will review your progress and plan the next steps together.

Food, activity, and muscle health still matter

Treatment works best with balanced meals, enough protein for your health needs, and regular activity. Strength training can help protect muscle during weight loss. We can help you choose realistic changes that fit your abilities and routine.

What about cost and compounded medications?

We will discuss insurance coverage, out-of-pocket costs, availability, and FDA-approved options. If you have questions about compounded medicines, we can review whether one is appropriate for a specific medical need. Compounded medicines are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality before they are marketed.

Let’s talk about your goals

Schedule a consultation to review your health history, ask questions, and find out which weight-management options may be right for you.